Differences between bloodstream infections involving gram-positive and gram-negative anaerobes.
暂无分享,去创建一个
F. Cobo | J. A. Garcia-Salcedo | J. Navarro-Marí | J. Rodríguez-Granger | A. Sampedro-Martínez | V. Pérez-Carrasco
[1] E. Urbán,et al. Incidence and Clinical Characteristics of Anaerobic Bacteremia at a University Hospital in Hungary: A 5-Year Retrospective Observational Study , 2022, Antibiotics.
[2] C. Lelubre,et al. Epidemiology and outcome of anaerobic bacteremia in a tertiary hospital. , 2022, European journal of internal medicine.
[3] F. Cobo,et al. Anaerobic bacteraemia: A score predicting mortality. , 2020, Anaerobe.
[4] M. Rasmussen,et al. Clinical and microbiological features of bacteraemia with Gram-positive anaerobic cocci: a population-based retrospective study. , 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[5] T. Tan,et al. Clinical characteristics and antimicrobial susceptibilities of anaerobic bacteremia in an acute care hospital. , 2017, Anaerobe.
[6] D. Yong,et al. Anaerobic Bacteremia: Impact of Inappropriate Therapy on Mortality , 2016, Infection & chemotherapy.
[7] Y. Hamada,et al. Clinical characteristics associated with mortality of patients with anaerobic bacteremia. , 2016, Anaerobe.
[8] I. Wybo,et al. Anaerobic bacteraemia: a 10-year retrospective epidemiological survey. , 2016, Anaerobe.
[9] R. Bellomo,et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.
[10] T. Rea,et al. Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.
[11] Y. Hamada,et al. Investigation of the risk factors of anaerobic bacteremia in a case-control study. , 2014, The Japanese journal of antibiotics.
[12] D. Church,et al. Population-based assessment of the incidence, risk factors, and outcomes of anaerobic bloodstream infections , 2013, Infection.
[13] M. Kostrzewa,et al. The value of MALDI-TOF MS for the identification of clinically relevant anaerobic bacteria in routine laboratories. , 2012, Journal of medical microbiology.
[14] A. Klindworth,et al. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies , 2012, Nucleic acids research.
[15] S. Ragot,et al. Prognostic factors and impact of antibiotherapy in 117 cases of anaerobic bacteraemia , 2008, European Journal of Clinical Microbiology & Infectious Diseases.
[16] J. Rosenblatt,et al. Reemergence of anaerobic bacteremia. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] T. Blackmore,et al. Bloodstream infections in a secondary and tertiary care hospital setting , 2006, Internal medicine journal.
[18] Y. De Gheldre,et al. A 62-month retrospective epidemiological survey of anaerobic bacteraemia in a university hospital. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[19] J. Zahar,et al. Incidence and clinical significance of anaerobic bacteraemia in cancer patients: a 6-year retrospective study. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[20] A. Limaye,et al. Risk Factors For Mortality In Patients With Anaerobic Bacteremia , 2004, European Journal of Clinical Microbiology and Infectious Diseases.
[21] R. Trevisan,et al. Anaerobe-induced bacteremia in Italy: a nationwide survey. The Italian Anaerobe Study Group. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] W. Wilson,et al. Anaerobic bacteremia. , 1972, Mayo Clinic proceedings.